SITC 2023 Election Voting for the 2023 SITC Election begins Tuesday, May 2! The election will be open for two weeks before closing on Tuesday, May 16 at 11:59 p.m. EDT. This year, SITC members will vote to select the society’s next Secretary/Treasurer and three At-Large Directors. Secretary...
Sept. 28–29, 2023 in Chicago or Aug. 9–10, 2023 Virtual The Women in Cancer Immunotherapy Network (WIN) is a SITC initiative seeking to promote and elevate women in the cancer immunotherapy field. Applications for the WIN Leadership Institute were due on April 11, 2023, at 5 p.m. PST and are now...
Cancer Immunotherapy Winter School Enduring materials now available Tailored to early-to-mid career scientists and clinicians in the field of cancer immunotherapy working in academic, clinical, industry and government settings, this hybrid program provides the best in cancer immunotherapy...
Advances in Cancer Immunotherapy™ is a CME- and CE-certified program for clinical oncologists, registered nurses, pharmacists and others involved in treating cancer patients with immunotherapy to learn basic immunology principles and the mechanisms and clinical applications of immunotherapy. ...
This webinar, the ninth and final session of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind natural killer cell engagers. Basic, clinical and translational researchers in academia and industry and members of the investment community are...
01-11-2023 | 10:00 - 12:00 CT
This webinar, the eighth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind therapies involving T cell receptors. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
12-07-2022 | 14:00 - 16:00 CT
This webinar, the seventh of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the enhanced blockade of cytotoxic T lymphocyte antigen-4 . Basic, clinical and translational researchers in academia and industry and members of the...
10-05-2022 | 13:00 - 15:00 CT
This webinar, the sixth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind induced pluripotent stem cell-derived cell therapies. Basic, clinical and translational researchers in academia and industry and members of the investment...
09-26-2022 | 10:00 - 12:00 CT
This webinar, the fourth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind the targeted systemic delivery of innate immune activators. Basic, clinical and translational researchers in academia and industry and members of the investment...
08-26-2022 | 10:00 - 12:00 CT
This webinar, the third of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind tumor-infiltrating lymphocyte therapies. Basic, clinical and translational researchers in academia and industry and members of the investment community are the...
07-28-2022 | 12:00 - 14:00 CT
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us